ZVRA Earnings Zevra Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–36 of 36
| Q2 2026 | 2026-06-30 | 0.14 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.60 | 2026-05-06 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 0.21 | 2026-03-09 | 10-K |
| FY 2025 | 2025-12-31 | 1.35 | 2026-03-09 | 10-K |
| Q3 2025 | 2025-09-30 | -0.01 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.21 | 2025-08-12 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.06 | — | — |
| FY 2024 | 2024-12-31 | -2.28 | — | — |
| Q3 2024 | 2024-09-30 | -0.69 | — | — |
| Q2 2024 | 2024-06-30 | -0.48 | — | — |
| Q4 2021 (derived) | 2021-12-31 | 0.84 | 2022-03-31 | 10-K |
| FY 2021 | 2021-12-31 | -2.11 | 2022-03-31 | 10-K |
| Q3 2021 | 2021-09-30 | -0.06 | 2021-11-10 | 10-Q |
| Q2 2021 | 2021-06-30 | -0.40 | 2021-08-13 | 10-Q |
| Q1 2021 | 2021-03-31 | -2.49 | 2021-05-14 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | -0.82 | — | — |
| FY 2020 | 2020-12-31 | -3.21 | — | — |
| Q3 2020 | 2020-09-30 | -0.68 | 2020-10-30 | 10-Q |
| Q2 2020 | 2020-06-30 | 0.21 | 2020-08-12 | 10-Q |
| Q1 2020 | 2020-03-31 | -1.92 | — | — |
| Q3 2019 | 2019-09-30 | 0.06 | 2019-11-14 | 10-Q |
| Q2 2019 | 2019-06-30 | -0.33 | 2019-08-13 | 10-Q |
| Q3 2018 | 2018-09-30 | -0.94 | — | — |
| Q2 2018 | 2018-06-30 | -0.91 | 2018-08-10 | 10-Q |
| Q4 2017 | 2017-12-31 | -0.72 | 2018-03-30 | 10-K |
| Q3 2017 | 2017-09-30 | -0.68 | — | — |
| Q2 2017 | 2017-06-30 | -0.44 | 2017-08-10 | 10-Q |
| Q1 2017 | 2017-03-31 | -1.11 | — | — |
| Q4 2016 | 2016-12-31 | -0.68 | 2017-03-10 | 10-K |
| Q3 2016 | 2016-09-30 | -0.92 | — | — |
| Q2 2016 | 2016-06-30 | -0.58 | 2016-08-11 | 10-Q |
| Q1 2016 | 2016-03-31 | -0.20 | — | — |
| Q4 2015 | 2015-12-31 | -0.64 | — | — |
| Q3 2015 | 2015-09-30 | -0.68 | — | — |
| Q2 2015 | 2015-06-30 | -2.45 | — | — |
| Q1 2015 | 2015-03-31 | -2.50 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.